Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - aminolevulinic acid hydrochloride, quantity: 10.2 mg (equivalent: aminolevulinic acid, qty 8 mg) - patch, dermal - excipient ingredients: polyethylene terephthalate; polyethylene; aluminium; ethyl acetate; acrylic acid; 2-ethylhexyl acrylate; methyl acrylate; glycidyl methacrylate; 2,2'-azobisisobutyronitrile; hexane - treatment of mild to moderate actinic keratoses (ak) lesions on the face and scalp (hairless areas).

European Union - English - EMA (European Medicines Agency)

photonamic gmbh & co. kg - 5-aminolevulinic acid hydrochloride - glioma - antineoplastic agents - gliolan is indicated in adult patients for visualisation of malignant tissue during surgery for malignant glioma (world health organization grade iii and iv).

Israel - English - Ministry of Health

tzamal bio-pharma ltd - 5-aminolevulinic acid hydrochloride - powder for solution - 5-aminolevulinic acid hydrochloride 1.5 g - aminolevulinic acid - gliolan® is indicated in adult patients for visualisation of malignant tissue during surgery for malignant glioma (who grade iii and iv).

Ireland - English - HPRA (Health Products Regulatory Authority)

photonamic gmbh & co. kg - 5-aminolevulinic acid hydrochloride - medicated plaster - 8 milligram(s) - sensitizers used in photodynamic/radiation therapy; aminolevulinic acid

Ireland - English - HPRA (Health Products Regulatory Authority)

galderma (uk) ltd - 5-aminolevulinic acid hydrochloride - medicated plaster - 8 milligram - sensitizers used in photodynamic/radiation therapy

Israel - English - Ministry of Health

tzamal bio-pharma ltd - 5-aminolevulinic acid as hydrochloride - powder for solution - 5-aminolevulinic acid as hydrochloride 1.5 g - aminolevulinic acid - aminolevulinic acid - gliolan® is indicated in adult patients for visualisation of malignant tissue during surgery for malignant glioma (who grade iii and iv).

European Union - English - EMA (European Medicines Agency)

biofrontera bioscience gmbh - 5-aminolevulinic acid hydrochloride - keratosis, actinic; carcinoma, basal cell - antineoplastic agents - treatment of actinic keratosis of mild to moderate severity on the face and scalp (olsen grade 1 to 2; see section 5.1) and of field cancerization in adults.treatment of superficial and/or nodular basal cell carcinoma unsuitable for surgical treatment due to possible treatment-related morbidity and/or poor cosmetic outcome in adults.

Singapore - English - HSA (Health Sciences Authority)

link healthcare singapore pte ltd - aminolevulinic acid 23.4mg/ml equivalent aminolevulinic acid hydrochloride - powder, for solution - aminolevulinic acid 23.4mg/ml equivalent aminolevulinic acid hydrochloride 30mg/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - aminolevulinic acid hydrochloride 10.2mg equivalent to aminolevulinic acid 8mg - dermal patch - 8 mg - active: aminolevulinic acid hydrochloride 10.2mg equivalent to aminolevulinic acid 8mg excipient: durotak 387-2353 scotchpak 1109 (baking film) pegoterate - treatment of mild to moderate actinic ketatoses (ak) lesions on the face and scalp.

Israel - English - Ministry of Health

perrigo israel agencies ltd, israel - 5-aminolevulinic acid as hydrochloride - gel - 5-aminolevulinic acid as hydrochloride 78 mg/g - aminolevulinic acid - treatment of actinic keratosis of mild to moderate intensity on the face and scalp (olsen grade 1 to 2).